Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2022-09-07 | 2022-09-23 | 168729 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-09-07 | 2023-10-05 | 168733 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2022-09-22 | 2023-04-28 | 169973 |
| TEVA-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-09-30 | 2023-01-19 | 170789 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2022-10-17 | 2023-06-09 | 172010 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2022-10-28 | 2023-01-18 | 173000 |
| TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2022-10-28 | 2023-10-03 | 173007 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2022-10-28 | 2022-11-12 | 173034 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-11-14 | 2023-02-02 | 174604 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2022-12-01 | 2023-07-05 | 176767 |
| NOVAMOXIN | 250MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-09 | 176770 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176836 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176839 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176848 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2022-12-01 | 2024-01-11 | 176851 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2022-12-22 | 2023-02-16 | 179191 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-12-22 | 2023-04-28 | 179297 |
| TEVA-GABAPENTIN | 400MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181617 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181628 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |